Company Filing History:
Years Active: 2021-2024
Title: Farzaneh Moghadam: Innovator in CRISPR Technology
Introduction
Farzaneh Moghadam is a prominent inventor based in Tempe, AZ (US). She has made significant contributions to the field of genetic engineering, particularly through her work with CRISPR technology. With a total of 4 patents, her innovations are paving the way for advancements in gene therapy and immunomodulation.
Latest Patents
Moghadam's latest patents include groundbreaking methods for modulating the human Cas9-specific host immune response. These methods aim to reduce undesirable T cell immune responses in patients undergoing gene therapy using CRISPR/Cas9-based genetic modulation. Another notable patent involves synthetic immunomodulation with a CRISPR super-repressor in vivo, which provides systems and methods to treat septicemia and Waldenström macroglobulinemia.
Career Highlights
Farzaneh Moghadam is affiliated with Arizona State University, where she continues to push the boundaries of genetic research. Her work has garnered attention for its potential to improve patient outcomes in gene therapy.
Collaborations
Moghadam collaborates with esteemed colleagues, including Samira Kiani and Mo Reza Ebrahimkhani, who contribute to her research endeavors.
Conclusion
Farzaneh Moghadam's innovative work in CRISPR technology exemplifies the potential of genetic engineering to transform medical treatments. Her contributions are vital to the ongoing evolution of gene therapy and immunomodulation.